| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.5 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |